The objective of this study was to determine if enteral leucine or branched-chain amino acid (BCAA) supplementation increases muscle protein synthesis in neonates who consume less than their protein and energy requirements, and whether this increase is mediated via the upregulation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway or the decrease in muscle protein degradation signaling. Neonatal pigs were fed milk replacement diets containing reduced energy and protein (R), R supplemented with BCAA (RBCAA), R supplemented with leucine (RL), or complete protein and energy (CON) at 4-h intervals for 9 (n = 24) or 21 days (n = 22). On days 9 and 21, post-prandial plasma amino acids and insulin were measured at intervals for 4 h; muscle protein synthesis rate and activation of mTOR-related proteins were determined at 120 min post-feeding in muscle. For all parameters measured, the effects of diet were not different between day 9 or day 21. Compared to CON and R, plasma leucine and BCAA were higher (P ≤ 0.01) in RL-and RBCAA-fed pigs, respectively. Body weight gain, protein synthesis, and activation of S6 kinase (S6K1), 4E-binding protein (4EBP1), and eukaryotic initiation factor 4 complex (eIF4E·eIF4G) were decreased in RBCAA, RL, and R relative to CON (P < 0.01). RBCAA and RL upregulated (P ≤ 0.01) S6K1, 4EBP1, and eIF4E·eIF4G compared to R. In conclusion, when protein and energy are restricted, both leucine and BCAA supplementation increase mTOR activation, but do not enhance skeletal muscle protein synthesis and muscle growth in neonatal pigs.
Introduction
Recent advances in the nutritional care of low birth weight (LBW) infants have improved the outcome of these patients (Kumar et al. 2017) . Nonetheless, LBW still represents the main cause of newborn deaths in the US (March of Dimes 2014). Nutritional deficiencies are a primary cause of growth faltering in LBW infants during the early weeks of life (Embleton et al. 2001; Rigo et al. 2002) . Both nutrient intolerance and the risk of developing feeding-related pathologies have led to the implementation of feeding protocols which do not meet the infant's nutrient requirements, and that often result in growth retardation with potential long-term adverse consequences (De Curtis and Rigo 2004; Berseth 2005) . Infants that remain smaller than those born full-term at term equivalent age are at risk of continued growth failure (Ehrenkranz 2007) , as well as developing type II diabetes (Whincup et al. 2008 ) and cardiovascular disease (Lapillonne and Griffin 2013; Atlantis et al. 2009 ). To increase lean mass accretion and minimize growth deficits in LBW infants, the use of diets above recommended protein intakes during the post-partum period has been proposed (Ziegler et al. 2002; Ehrenkranz 2007) . However, feeding high protein formulas to neonates has been associated with increased levels of blood urea and ammonia (Hay 2008) , suggesting that significant amounts of amino acids (AA) in the diet may be catabolized instead of being used for anabolic purposes (Hay 2008) .
On the basis of studies in cells and rodents demonstrating anabolic effects of leucine (Leu) independent of its function as a substrate for protein synthesis, there has been recent interest in the potential use of supplemental Leu to improve overall nitrogen (N) retention and muscle growth. The previous studies in rodent models and humans have shown a stimulatory effect of Leu on protein synthesis in aged populations (Rieu et al. 2006 ) and post-exercise (Pasiakos et al. 2011 ). As such, Leu inclusion in the diet may also have the potential to improve the efficiency of dietary amino acid use for muscle protein synthesis and overall growth in LBW infants while avoiding the generation of excessive amounts of N waste products. Previously, we showed that both oral and parenteral administrations of Leu to neonatal pigs enhance muscle protein synthesis in the short term by increasing the phosphorylation of the mechanistic target of rapamycin complex 1 (mTORC1) and its downstream effectors, namely, ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor 4 (eIF4)-binding protein 1 (4EBP1; Escobar et al. 2005; Wilson et al. 2010; Torrazza et al. 2010; Suryawan et al. 2012 ; Fig. 1 ). Furthermore, when a Leu supplement was delivered as a pulse to an otherwise complete diet over a more extended period, rates of protein synthesis and lean mass accretion were increased (Boutry et al. 2016) . Nonetheless, Leu supplementation did not improve muscle growth in neonatal pigs when energy and protein ) intakes were restricted, despite an increase in mTOR pathway activation. This lack of efficacy on growth was associated with a decline in the post-prandial circulating valine (Val) and isoleucine (Ile) concentrations, which may have limited the protein synthetic activity in skeletal muscle . Consequently, in the present study, we hypothesized that the efficiency of protein deposition in neonates would increase in response to supplementation of the diet with all BCAA when protein and energy intakes are restricted, and that this increase would be mediated through an increase in muscle protein synthesis via the upregulation of the mTORC1 pathway.
Previously, we showed that the longissimus dorsi (LD) muscle, which contains primarily fast-twitch glycolytic fibers, undergoes a more rapid decline in protein synthetic activity during the early weeks of life compared with muscles that contain more slow oxidative fibers, such as the soleus and gastrocnemius (Davis et al. 1989 (Davis et al. , 2002 . As such, the LD, soleus, and gastrocnemius were assessed individually at two different developmental stages to account for potential interactions between Leu or BCAA content and fiber composition, which could mask the effect of the diet on protein synthetic activity or mTORC1 activation pathway in skeletal muscle. Finally, the effects of BCAA supplementation and supplementation with Leu alone on muscle protein degradation signaling, insulin resistance, and amino acid transporter expression under energy and protein restriction conditions were assessed.
Materials and methods

Animals and experimental design
The experimental design is depicted in Fig. 2 . Experiments were carried out in accordance with the Institutional Animal Care and Use Committee of Baylor College of Medicine and conducted in accordance with the National Research Council´s Guide for the Care and Use of Laboratory Animals (2011). Forty-six crossbred piglets (Sus scrofa, Yorkshire × Landrace × Hampshire × Duroc; Agriculture Headquarters, Texas Department of Criminal Justice, Huntsville, TX, USA) were weaned when 2-day-old and 2.1 ± 0.2 kg body weight (BW) in two consecutive groups that were euthanized at 12 and 24 days of age, respectively. All animals were housed in individual stainless steel cages in temperature-controlled rooms (28 °C), with additional zone heating provided if required. Pigs were bowl-fed ad libitum a commercial milk replacement diet (Soweena ® Dry Fat 7-60™; Merrick Animal Nutrition, Middleton, WI, USA) until 4 days of age. At 3 days of age, piglets were anesthetized with isoflurane (PPC, Richmond Hill, Ontario, CAN) after an overnight fast, and a catheter was placed surgically in the left jugular vein using sterile technique (Davis et al. 1996) . The catheter was flushed with sterile heparinized saline solution (100 IU mL −1 ; APP, Lake Zurich, IL, USA) every 48 h, and maintained with a heparin lock. At the same time, a gastric tube was inserted surgically for intra-gastric feeding. The day of the surgery was considered as day 0 of the study.
On the day after surgery, all piglets were randomly assigned to receive 1 of 4 liquid diets (Tables 1, 2) : (1) control (CON; n = 6): 15 g CP and 215 kcal ME [kg body weight (BW) −1 · day −1 ]; (2) restricted + BCAA (RBCAA; n = 6): 10.5 g CP supplemented with 1.65 g BCAA and 156.2 kcal ME; (3) restricted + Leu (RL; n = 6): 10.5 g CP supplemented with 1.19 g L-Leu and 154.8 kcal ME; and (4) restricted (R; n = 6): 10.5 g CP and 150.7 kcal ME. The CON diet was formulated to exceed by 10% the nutrient requirements of 5-6 kg pigs including the indispensable AA requirements, according to NRC (2012), whereas RBCAA, RL, and R diets were formulated to be 20% below CP and ME requirements, but to meet requirements for all other nutrients (Tables 1, 2 ). The desired CP reductions were achieved by reducing both whey and casein in the diet. Dietary levels of Leu, Ile, and Val in RL and RBCAA diets were formulated to match or exceed those in the CON diet. In addition, alanine (Ala) was added to diet R to make the three restricted diets isonitrogenous. Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTORC1, leading also to an increase in protein translation initiation via S6K1 and eIF4G·eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTORC1 pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy F-Box/Atrogin-1 (MAFbx/Atrogin-1) and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation Protein-to-energy ratio and lactose content were kept constant across diets. Animals were fed 40 mL · kg BW −1 at 4-h intervals six times per day, with the milk replacement delivered over a 20 min period. Feeding was increased gradually to achieve full feeds at day 3 post-surgery.
Body weights (BW) were recorded every 3 days, and average daily gain (ADG) and feed efficiency were calculated for both days 0-9 and 9-21 time periods. Animals in the first group (n = 24) were euthanized at day 9 of the study (12 days of age), and those in the second group (n = 24) at day 21 (24 days of age), using an injection of pentobarbital sodium (0.4 mL kg · BW −1 ; ScheringPlough, Union, NJ, USA). Tissue samples were obtained from the longissimus dorsi (LD), gastrocnemius, and soleus muscles, heart, and liver. Tissue was weighed, frozen in liquid N, and stored at − 80 °C until analyzed. Quantitative assessment of fat and lean body composition was performed only in animals euthanized on day 21 using dual-energy X-ray absorptiometry (DXA; Columbus et al. 2015) 1 day before surgery and on day 18 of the study. Animals were sedated with an intramuscular injection of telazol (2.2 mg · kg BW −1 ; Zoetis, Florham Park, NJ, USA,) and xylazine (1.1 mg · kg BW −1 ; Lloyd Laboratories, Shenandoah, IA, USA). Scans were performed using a Hologic Delphi-A scanner (Hologic, Bedford, MA, USA) and analyzed using the manufacturer's software (version 11.2, Hologic, Inc., Waltham, MA, USA). Body composition data were adjusted according to Koo et al. (2004) to correct Hologic DXA Infant Scan Mode results to more accurately estimate piglet body composition.
Plasma insulin, glucose, and amino acids
Blood was sampled from the jugular vein immediately before feeding and at 30, 60, 90, 120, 180 , and 240 min post-feeding on day 9 (group 1) and day 21 (group 2). Samples were centrifuged at 12,000×g for 2 min, and plasma was stored at − 20 °C. Insulin (µU · mL −1 ) was measured using a porcine insulin radioimmunoassay kit (Millipore, St. Charles, MO, USA), while glucose levels (mg · dL −1 ) were determined by the glucose oxidase method (Thermo Scientific, Waltham, MA, USA). Insulin resistance from basal (fasting) glucose and insulin concentrations was estimated using the homeostatic model assessment (HOMA), according to the formula: [fasting insulin (µU · mL −1 ) × fasting glucose (mg · dL −1 )]/405 (Matthews et al. 1985) . Plasma-free AA concentrations were quantified by high-performance liquid chromatography (HPLC; PICO-TAG reverse-phase column; Waters, Mildford, MA, USA) using an analytical method based on deproteinization and derivatization of AA with phenylisothiocyanate (Burrin et al. 1995) .
Protein synthesis rate
Ninety minutes after feeding, animals were injected via the jugular vein catheter with 10 mL · kg BW −1 of a flooding Fig. 2 Outline of the experimental protocols. Four groups of 2-dayold piglets were assigned to 1 of 4 diets fed at 4-h intervals for 9 (n = 24) and 21 days (n = 22). Catheters were placed surgically in the left jugular vein and stomach on day 0 of the study. Quantitative assessment of fat and lean body composition was performed using dual-energy X-ray absorptiometry on days − 1 and 18. Body weights were recorded every 3 days. Blood levels of circulating insulin, glucose, and free AA were measured on days 9 and 21 at 0, 30, 60, 90, 120, 180, and 240 min post-feeding. Protein synthesis rate was measured on days 9 and 21, followed by euthanasia and tissue collection dose of L-[4-3 H]Phe (American Radiolabeled Chemicals, St. Louis, MO, USA) which provided 1.5 mmol Phe · kg BW −1 and 1 mCi of L-[4-3 H] Phe · kg BW −1 . Plasma samples were collected at 5, 15, and 30 min after injection and stored at − 20 °C for measurement of the free Phe specific radioactivity of the blood pool. Piglets were euthanized immediately after the last blood sample and tissues were collected. Free and protein-bound Phe in tissues were measured by HPLC using an anion-exchange column (PA1 column; Dionex, Sunnyvale, CA, USA) followed by post-column derivatization, as previously described (Davis et al. 1999) . Fractions were collected, and the radioactivity associated with the phenylalanine peak was measured by liquid scintillation counting (Tri-Carb 2500TR; Packard Instrument, Meriden, CT, USA).
The fractional rate of protein synthesis (K S : % of protein mass synthesized per day; % · day −1 ) for each tissue was calculated as where S b (dpm · min −1 ) is the specific radioactivity of the protein-bound Phe, S a (dpm · min −1 ) is the specific radioactivity of the tissue-free Phe calculated from the specific radioactivity at the time of the tissue collection corrected for the change over the labeling period from the linear regression of the blood specific radioactivity at 5, 15, and 30 min against time, and t is the labeling time in minutes of the specific tissue. The previous studies have demonstrated that, after a flooding dose of
Translational efficiency and capacity
To assess whether changes in fractional rate of protein synthesis are due to changes in ribosomal abundance and/ or translational efficiency, total muscle protein was quantified using the Pierce BCA assay (Thermo Scientific, Rockford, IL, USA) (Lowry et al. 1951 ) and total muscle RNA content was quantified according to Munro and Fleck (1966) . Ribosomal abundance, a measure of protein synthetic capacity (C S ), was estimated as the total RNAto-protein ratio (i.e., mg RNA · g protein −1 ), given that the majority of RNA in the tissue is ribosomal (Fiorotto et al. 2000) . Ribosomal translational efficiency, namely, protein synthetic efficiency (K RNA ), was estimated as the total protein synthesized per total RNA (i.e., g protein · g RNA −1 ).
Western Blot analysis
Equal amounts of protein samples were electrophoretically separated on polyacrylamide gels (PAGE; C.B.S Scientific, Del Mar, CA, USA) and transferred to PVDF membranes (Pall Corporation, Pensacola, FL, USA). The membranes were incubated overnight with primary antibodies, followed by 1-h incubation with secondary antibody. Blots were developed using an enhanced chemiluminescence kit (GE Health Sciences, Buckinghamshire, UK), visualized, and analyzed using a ChemiDoc-It Imaging System ® (UVP, Upland, CA, USA). For normalization, immunoblots performed with anti-phosphospecific antibodies were exposed to stripping buffer (Pierce Biotechnology, Rockford, IL, USA) and reprobed with nonphosphospecific antibodies against total protein (Cell Signaling, Danvers, MA, USA), as previously described . Primary antibodies used were against ribosomal protein S6 kinase (S6K1 Thr 389 and total; Cell Signaling Technology; Beverly, MA, USA), eukaryotic initiation factor 4 (eIF4E)-binding protein-1 (4EBP1 Thr 70 and total; Cell Signaling Technology), insulin receptor substrate 1 (IRS1 Ser 1101 and total; Cell Signaling Technology), protein kinase B (PKB Ser 308 and total; Cell Signaling Technology), Na + -coupled neutral AA transporter 2 (SNAT2; Aviva Systems Biology, San Diego, CA, USA), L-type AA transporter 1 (LAT1; Thermo Scientific, Rockford, IL, USA), the AMP-activated protein kinase alpha (AMPKα Thr 172 and total; Cell Signaling Technology), muscle atrophy F-box/Atrogin-1 (ECM Biosciences, Versailles, KY, USA), muscle RING-finger protein 1 (MuRF1; R&D Systems, Minneapolis, MN, USA), forkhead box protein O1 (FOXO1 Ser 256 and total; Cell Signaling Technology), and extracellular signal-regulated kinases 1 and 2 (ERK1/2 Thr 202 /Tyr 204 and total; Cell Signaling Technology). The eukar yotic initiation factor 4 complex (eIF4E·eIF4G) was immunoprecipitated using an antieIF4E monoclonal antibody obtained from aliquots of fresh tissue homogenates (gift of Dr. Leonard Jefferson, Pennsylvania State University, College of Medicine, Hershey, PA, USA). Briefly, muscle homogenates were processed as previously described (Suryawan et al. 2001) and immediately subjected to protein immunoblot analysis using rabbit anti-eIF4G (Bethyl Laboratories, Montgomery, TX, USA). Amounts of eIF4G were corrected by the eIF4E (Cell Signaling Technology) recovered from the immunoprecipitates. 
Statistical analyses
Data were analyzed by a three-way ANOVA using linear mixed models in SAS 9.2 (SAS Institute Inc., Cary, NC, USA), with diet (CON, RBCAA, RL, and R), muscle (LD, gastrocnemius, and soleus), day of study (days 9 and 21), and their interactions as fixed effects and initial body weight as covariate. A repeated measurement statement was included for parameters measured repeatedly post-feeding, with the structure of the covariance selected based on smallest Akaike information criterion. If an interaction was found to be not significant, it was removed from the model and the data reanalyzed. Normality of the residuals and presence of outliers were assessed in SAS. Non-normally distributed parameters were power transformed by a parameter φ, whose optimal value was estimated using the maximum likelihood (ML) method (Piepho 2009) . P values for pre-planned pairwise comparisons were calculated using Student's t tests. Data were presented as least square mean ± SE. Significant effects were considered at P ≤ 0.05 and trends at P ≤ 0.1.
Results
Body weight, body composition, average daily gain, and tissue weights
The effect of diet on BW, ADG, and feed efficiency during the first 9 days of study was not significantly different (P = 0.61) between animals euthanized on day 9 and day 21 (i.e., groups 1 and 2), so data for this time period were combined for analysis (n = 46). Values between days 9 and 21 of the study pertain only to animals euthanized on day 21 (n = 22). There were no differences in initial BW among the four groups (Fig. 3) . Piglet BW was higher for CON compared to RBCAA, RL, and R on day 9 (P ≤ 0.01), day 12 (P ≤ 0.001), day 15 (P ≤ 0.001), day 18 (P ≤ 0.001), and day 21 (P ≤ 0.001) of age. Average daily gain and feed efficiency were also higher in CON compared to RBCAA, RL, and R between 0-9-and 9-21-day intervals (P ≤ 0.001; Table 3 ). There were no differences in lean and fat body mass between animals prior to the study (Table 3) . Total lean mass on day 18 and lean mass gain between days 0 and 18 were greater in CON compared to RBCAA, RL, and R (P ≤ 0.001), whereas total fat mass on day 18 did not differ among treatments (Table 3) . Weight of the LD (P ≤ 0.0001) and liver (P ≤ 0.001) was lower in RBCAA, RL, and R groups than CON on days 9 and 21 and of the heart (P ≤ 0.01) on day 21 (Table 4) . Compared to CON, gastrocnemius weight was lower in RL and RBCAA (P ≤ 0.05) and soleus weight was lower in RBCAA and R (P ≤ 0.05) on day 21. Weight increased significantly for all tissues between days 9 and 21 (P ≤ 0.05).
Insulin, glucose, and free AA levels
Fasting insulin levels were higher (P < 0.05) in CON compared to RBCAA, RL, and R at both day 9 and day 21 (Table 5) . Likewise, HOMA values were also higher (P < 0.05) in CON compared to RBCAA, RL and R on days 9 and 21 (Table 5 ). There were no differences in postprandial plasma levels of glucose and insulin among diets at either days 9 and 21 during 4-h post-feeding (P = 0.89 and 0.56 for insulin and glucose, respectively; data not shown). The effect of diet on post-prandial levels of plasma AA was not different between animals euthanized on day 9 and day 21 (i.e., P values for the interaction diet × time (after feeding) × day was not significant; data are shown in Online Resource Table 1A ), so only results pertaining to diet × time effect are discussed (Fig. 4) . Supplementation of Leu or RBCAA in the diet increased plasma Leu levels in both RL and RBCAA groups compared to CON and R between 0 and 240 min post-feeding (P ≤ 0.001; Fig. 5a ), whereas it decreased Ile and Val levels in RL between 0 and 240 min (P ≤ 0.001; Fig. 5b, c) . Plasma levels of proline, glutamate, aspartate, and serine were higher (P ≤ 0.05) in CON compared to RBCAA, RL, and R at different time postfeeding. Data are included as online Supplemental Material along with the remainder of values for plasma EAA and NEAA (Online Resource Fig. 1A-Q) .
Protein synthesis rate
The interactions diet × muscle × day, diet × day, and diet × muscle for K S , C S , and K RNA parameters were all not significant (P values are shown in Online Resource Table 1A ), so only the effect of diet and muscle × day of study are discussed (Figs. 5, 6 ). Fractional protein synthesis rate (K S ) was greater in CON compared to RBCAA, RL, and R groups (P ≤ 0.01; Fig. 5a ). Likewise, K RNA was greater in CON compared to RBCAA, RL, and R (P ≤ 0.01; Fig. 5c ), while C S was not different among diets (Fig. 5b) . Between days 9 and 21, K S decreased in LD (P ≤ 0.001; Fig. 6a ), as well as C S (P ≤ 0.001; Fig. 6b ) but not K RNA (P = 0.34; Fig. 6c ). Conversely, K S did not change between day 9 and day 21 in either soleus (P = 0.33; Fig. 6a ) or gastrocnemius (P = 0.56; Fig. 6a ). C S decreased in both muscles (P ≤ 0.001; Fig. 6b ), while K RNA increased in soleus and tended to increase in gastrocnemius (P ≤ 0.001 and = 0.1, respectively; Fig. 6c ).
Protein signaling and amino acid transporter abundance
The interactions diet × muscle × day, diet × day, and diet × muscle for protein signaling and AA transporter abundances were all not significant (P values are shown in Online Resource Table 1B) , so only the effects of diet and muscle × day of study are discussed. There were no differences in phosphorylation of IRS1 (Ser 1101 ) among groups (Fig. 7a) . Phosphorylation of PKB (Thr 308 ) was higher in both CON and RBCAA groups compared to RL and R (P ≤ 0.05; Fig. 7b ). Phosphorylation of S6K1 (Thr 389 ) and 4EBP1 (Thr 70 ) was higher in RL and RBCAA compared to R (P ≤ 0.01), and in CON compared to RBCAA and RL (P ≤ 0.01; Fig. 7c, d) . Likewise, the formation of the active eIF4E·eIF4G complex was higher in RL and RBCAA compared to R (P ≤ 0.05), and increased further in the CON group (P ≤ 0.05; Fig. 7e Fig. 7f ) did not differ among groups. Phosphorylation of FOXO1 (Ser 256 ) was higher in CON compared to R (P ≤ 0.05; Fig. 8b ) and was intermediate in RBCAA and RL groups. There were no differences among groups in the phosphorylation of AMPKα (Thr 172 ) (Fig. 8a ) and in the protein abundance of LAT1, SNAT2, Atrogin1, and MuRF1 (Fig. 8c-f) .
Figures representing the developmental effects on muscle IRS1, PKB, S6K1, 4EBP1, AMPKα, FOXO1, and ERK1/2 phosphorylation, and eIF4E·eIF4G, LAT1, SNAT2, Atrogin-1, and MuRF1 abundance are included as online Supplemental Material (Online Resource Figs. 2 and 3) . 
Discussion
Despite improvements in the nutritional management of LBW infants, their extrauterine growth frequently falters, in part due to the inadequate intake of protein during the early weeks of postnatal life (Embleton et al. 2001; Rigo et al. 2002; de Curtis and Rigo 2004) . Although premature infants may be provided parenteral nutrition initially, the goal is to transition them to enteral feeding as soon as it can be tolerated (Berseth 2001) . However, the switch to oral feedings is limited by the concern of the infant´s ability to metabolize the nutrients offered and the risk of developing feeding-related pathologies (Berseth 2005) which often leads to dietary protein intakes that cannot support maximal growth (Embleton et al. 2001; Rigo et al. 2002) . Using the neonatal pig as a model, our laboratory has demonstrated a dual effect of dietary Leu in promoting muscle protein accretion in newborns, by acting as an essential AA (EAA) in protein synthesis and also by modulating the intracellular signaling pathways that regulate translation initiation (Torrazza et al. 2010; Suryawan et al. 2012; Columbus et al. 2015; Boutry et al. 2016) . Given that the clinical condition of LBW infants often precludes their consumption of full feeds over protracted lengths of time, in the present study, we assessed the potential for using oral Leu supplementation alone, or in combination with Ile and Val, to enhance the lean growth of neonatal pigs when both protein and energy intakes are suboptimal for an extended period. 
Leu or BCAA supplementation does not improve growth in protein-and energy-restricted neonates
Previously, we showed that when CP and ME intake were restricted by 30%, Leu supplementation increased mTORC1 activation in skeletal muscle of neonate pigs, but did not improve protein synthetic activity or muscle mass growth . In light of these findings, we hypothesized that leucine supplementation could enhance muscle protein synthesis if the reductions in dietary protein and energy intake were less severe. However, supplementation of Leu or BCAA when CP and ME intakes were restricted to only 20% below CP and ME requirements did not lead to an improvement in piglet body weight gain or muscle K S when compared to an unsupplemented restricted diet, despite an increase in the signaling pathways that promote translation initiation. These results suggest that substrate availability may be critical for Leu to increase protein synthesis, and support results from the previous studies, where dietary Leu did not maintain increased rates of muscle protein synthesis in adult humans beyond 3-h post-feeding when it was supplemented in a suboptimal single bolus of protein (Churchward-Venne et al. 2012) . Similarly, long-term infusion of Leu failed to sustain increased rates of muscle protein synthesis in neonate pigs unless additional AA were administered concurrently (Wilson et al. 2010; Escobar et al. 2007 ). It its noteworthy that an increase in daily BCAA intake in adult humans undergoing 19-day caloric restriction increased body fat loss without inducing changes in lean mass (Mourier et al. 1997) .
In assessing the metabolic effects of Leu or BCAA supplementation in a restricted diet, the negative effect of energy restriction on N retention in neonatal pigs cannot be discounted, as large amounts of dietary AA may have been catabolized for energy production instead of being used as substrate for protein synthesis. Data from LBW infants fed different energy intakes at the same protein level showed an increase in N utilization in parallel with higher energy intake (Duffy et al. 1981) , whereas a positive relationship between energy intake and N retention levels was observed in young pigs (Campbell and Dunkin, 1983) and lambs (Black and Griffiths, 1975) . Furthermore, long-term supplementation of pigs with Leu or BCAA in diets that were 30% CP-restricted, but with normal energy intake, resulted in an increase in mTOR Fractional rates of protein synthesis (K S ), protein synthetic capacity (C S ), and protein synthetic efficiency (K RNA ) in longissimus dorsi, gastrocnemius, and soleus of piglets fed control (CON), restricted + BCAA (RBCAA), restricted + Leu (RL), or restricted (R) diets for 9 (n = 24) and 21 days (n = 22). Values are least square mean ± SE pathway activation and muscle protein synthesis (Yin et al. 2010; Zhang et al. 2013; Columbus et al. 2015) , as well as greater ADG (Yin et al. 2010; Zhang et al. 2013) in both neonatal and weaned pigs. As such, the chronic ME deficit induced by the restricted diet in the current study may have contributed to the lack of anabolic effect of Leu or BCAA supplementation on neonatal muscle protein synthesis, despite enhanced activation of the mTORC1-signaling pathway, as evidenced by increased S6K1 and 4EBP1 phosphorylation and eIF4E·eIF4G formation. Interestingly, phosphorylation of ERK1/2 and AMPKα did not differ among CON and restricted diets, even though activation of both proteins has been shown to increase under chronic caloric restriction conditions in skeletal muscle of monkeys and rats (Nadeau et al. post-prandial plasma levels of Val and Ile decreased in response to Leu supplementation, likely due to the Leuinduced upregulation of the activity of the branched-chainketo acid dehydrogenase enzymatic complex in BCAA oxidation (Tannous et al. 1963; Harper et al. 1970) . This led us to speculate that both AA may have become rate-limiting for protein synthesis in neonatal pigs ). However, we now have shown that BCAA supplementation does not enhance muscle protein synthesis compared to RL or R, despite preventing the decline in plasma Val and Ile concentrations. Interestingly, plasma Leu concentrations were greater in the BCAA compared RL group, despite Leu intake being matched. Given that Leu, Ile, and Val are all oxidized by the same enzymatic complex, it is possible that an increase in the amount of total enzymatic substrate may have lowered the rate of Leu oxidation, hence increasing Leu circulating levels. Alternatively, having higher Val and Ile competing for the AA transporters in the BCAA group may have decreased the amount of Leu taken up into the cells compared to RL. We cannot discount the possibility that AA other than Leu stimulate muscle protein synthesis through mTORC1, and thus contribute to the higher protein synthesis rates in the CON group. For example, arginine and glutamine are known to increase S6K1 and 4EBP1 phosphorylation in pig trophoblasts (Kim et al. 2013 ) and enterocytes (Ban et al. 2004) , whereas threonine and Ile activated the mTORC1 pathway in murine embryonic stem cells (Ryu and Han 2011) and skeletal muscle of rats (Anthony et al. 2000) . Nonetheless, only proline was significantly decreased in the RBCAA and RL groups compared to CON, rendering unlikely that changes in muscle protein synthesis rate between diets were related to differences in EAA circulating levels in the present study.
Leu or BCAA supplementation may not ameliorate protein degradation signaling in skeletal muscle
The previous studies have identified the transcription factor FOXO1, as well as ubiquitin ligases Atrogin-1 and MuRF1, as key regulators of skeletal muscle proteolysis (Sandri et al. 2004; Stitt et al. 2004 ). In normal, growing myotubes and adult muscle fibers, the IGF-PI3K-AKT pathway suppresses the expression of Atrogin-1 and MuRF1 through phosphorylation of FOXO1, leading to its sequestration in the cytoplasm away from target genes (Sandri et al. 2004; Stitt et al. 2004 ). In addition, phosphorylation of AMPKα has also been shown to enhance proteolysis by increasing Atrogin-1 and MuRF1 expression through activation of FOXO1 (Krawiec et al. 2007 ). Phosphorylation of FOXO1 decreased in R but not RBCAA or RL groups compared to CON, which may indicate some reduction in protein degradation signaling by Leu and BCAA; however, the nuclear import of FOXO1 was not confirmed in the present study.
In addition, expression of ubiquitin ligases and activation of AMPKα did not differ between diets, suggesting that the ubiquitin/proteasome pathway may be unchanged in the present condition. We cannot discard a possible decrease in protein degradation in response to BCAA and Leu supplementation via inhibition of the cellular autophagy systems. In this regard, previously, we have observed decreased levels of microtubule-associated protein light 1 chain 3 subunit II (LC3-II), a protein which parallels the development of autophagosome (Wang et al. 2011; Kabeya et al. 2000) , in response to Leu supplementation under septic (HernandezGarcía et al. 2016 ) and normal conditions (Boutry et al. 2013 ) in neonate pigs. Nonetheless, the autophagy-lysosomal degradation pathways were not assessed in the current study.
Leu or BCAA supplementation does not induce insulin resistance in skeletal muscle of neonate pigs
Studies in cultured myotubes and isolated rat skeletal muscles suggest that Leu and BCAA can impair insulin-mediated glucose uptake through a negative-feedback loop (Iwanaka et al. 1985; Tremblay et al. 2007) , presumably mediated by mTOR-S6K1 phosphorylation and subsequent serine phosphorylation and inactivation of IRS-1 (Iwanaka et al. 1985; Tremblay et al. 2007) . As such, we tested the hypothesis that the inclusion of Leu and BCAA in the restricted diets would increase insulin resistance through phosphorylation of IRS1 on Ser 1011 (Tremblay et al. 2007 ), leading to a decrease in the phosphorylation of PKB and overall protein synthesis in the neonate pigs. However, IRS1 phosphorylation in muscle tissue did not differ between CON and restricted diets, and HOMA values in blood were lower in all groups compared to CON, providing further evidence that insulin signaling was not impaired in RBCAA-and RL-supplemented animals.
Supplementation of Leu or BCAA in the diet does not upregulate AA transporters abundance in skeletal muscle of neonate pigs
Beyond their classical function of transporting Leu, Ile, and Val across membranes, LAT1 and SNAT2 transporters have also been implicated in mTORC1 activation by sensing and signaling AA availability to the mTOR pathway (Hundal and Taylor 2009). In addition, LAT1 and SNAT2 have been shown to increase their expression in skeletal muscle in response to higher EAA levels (Drummond et al. 2010 ). Although we cannot discard a regulatory effect of LAT1 and SNAT2 in the activation of mTORC1-signaling pathway in the present study, the increase in S6K1 and 4EBP1 phosphorylation and eIF4E·eIF4G formation in CON, Leu, and BCAA groups was not associated with an increase in the expression of these AA transporters in skeletal muscle.
Protein abundance and phosphorylation are developmentally regulated in skeletal muscle of neonate pigs
We have previously reported that feeding (Davis et al. 1996 and insulin (Wray-Cahen et al. 1998 ) and Leu infusion (Escobar et al. 2007 ) can stimulate muscle protein synthesis to a lesser extent in older than in younger pigs. Similarly, results presented herein indicate that muscle protein synthesis rates and the activation of mTORC1 effectors decreased in LD of neonatal pigs between days 9 and 21, although no changes were observed in the gastrocnemius and soleus. Developmental differences in K S between muscles likely are attributable to different myofiber composition (Davis et al. 1989 (Davis et al. , 2002 . The gastrocnemius and soleus are composed partially and entirely of slow oxidative fibers, respectively, whereas the LD contains fast-twitch, glycolytic fibers (Ariano et al. 1973; Kelly et al. 1984) which undergo a more rapid decline in protein synthetic activity during the early weeks of life (Davis et al. 1989) . Similarly, the lower MuRF1 and Atrogin-1 abundance observed in LD of older pigs, along with the increase in phosphorylation of FOXO1, suggests a parallel developmental decrease in protein degradation rates in the skeletal muscle. Paradoxically, activation of ERK1/2, which also is upregulated by insulin (Gosmanov et al. 1985) and promotes mTORC1 activity and protein synthesis in skeletal muscle (Mccubrey et al. 2011) , was augmented in LD and gastrocnemius between days 9 and 21 across all groups. Although speculative, this effect may be a consequence of the developmental increase in post-prandial insulin levels observed in the study (data not shown), as well as an increase in muscle activity (Gosmanov et al. 1985) associated with piglet growth (Brown et al. 2015) .
Consistent with the previous findings in neonatal pigs (Davis et al. 1996) and rats (Davis et al. 1989) , ribosomal abundance, estimated as the total RNA-to-protein ratio (i.e., mg RNA · g protein −1 ), decreased between days 9 and 21 resulting in a significant reduction of the muscle protein synthetic capacity (C S ) in all three muscles. These data suggest that during the neonatal period, the age-related decline in K S occurs primarily as a result of a decrease in the muscle C S , whereas the feeding-induced stimulation of protein synthesis rate appears to be related to an increase in ribosomal translational efficiency (K RNA ), estimated as the total protein synthesized per total RNA (i.e., g protein . g RNA −1 ). Interestingly, the steep decline in C S did not cause a decrease in the K S in soleus or gastrocnemius, as it was accounted for by the increase in K RNA in both muscles. These results are consistent with data from Davis et al. (1989) , which also indicated a precocious increase in K RNA in soleus in 16-day-old rats, resulting in higher K S protein synthetic activity compared to glycolytic muscles during the early weeks of life.
In conclusion, supplementation of Leu or all BCAA to a protein-and energy-restricted diet did not enhance fractional protein synthesis rates in skeletal muscle nor body weight or lean gain of neonatal pigs, even though it upregulated the activity of the signaling proteins involved in protein translation initiation. Further studies are needed to investigate whether long-term enteral Leu supplementation will enhance lean mass accretion in neonates when energy intake is less restricted.
